This site is intended for healthcare professionals only.

This site is intended for healthcare professionals only.

Tailored Education for the Multidisciplinary Team

Menu

Tailored Education for the Multidisciplinary Team

About the program

Biomarkers play an increasingly important role in the timely detection, diagnosis, and management of Alzheimer’s disease. This expert-led program offers educational resources to support healthcare professionals across the multidisciplinary care team to implement advances in biomarkers to improve the diagnosis and management of patients with Alzheimer’s disease.

Key topics include:

  • Using biomarker tests and interpreting results to support an accurate diagnosis of Alzheimer’s disease
  • Establishing a shared decision-making approach with patients and caregivers from diagnosis to ongoing management
  • Applying biomarker testing to guide treatment and management strategies for better patient outcomes

Learn more about the educational activities below.

Select your role below to hear from the expert faculty on why this program is relevant for you!

In this video, Professor Dorota Religa…

Sign up now to access expert-led education and practical insights on biomarker-driven Alzheimer’s disease care.

In this video, Professor Hitoshi Shimada provides an overview of the importance of biomarkers in Alzheimer’s disease and why this educational program will be valuable for imaging physicians working as part of the Alzheimer’s disease multidisciplinary care team.

Sign up now to access expert-led education and practical insights on biomarker-driven Alzheimer’s disease care.

In this video, Dr Chuck Vega highlights the incidence of Alzheimer’s disease in the United States and why this educational program will be valuable for physicians navigating the care of these patients in the primary care setting.

Sign up now to access expert-led education and practical insights on biomarker-driven Alzheimer’s disease care.

In this video, Dr Carolyn Clevenger discusses the role of a nurse practitioner in the care continuum for people living with Alzheimer’s disease and why the educational resources from this program will be helpful as an Alzheimer’s disease care navigator.

Sign up now to access expert-led education and practical insights on biomarker-driven Alzheimer’s disease care.

In this video, Professor Robert Perneczky highlights why this educational program is relevant for all healthcare professionals involved in the diagnosis and care of patients with Alzheimer’s disease.

Sign up now to access expert-led education and practical insights on biomarker-driven Alzheimer’s disease care.

In this video, Professor Dorota Religa…

Sign up now to access expert-led education and practical insights on biomarker-driven Alzheimer’s disease care.

REGISTER FOR ACCESS

Explore the education

Video

Multidisciplinary video

  • 15 minutes

Hear from the expert faculty on the current challenges in using biomarkers when diagnosing and managing early-stage Alzheimer’s disease and the value of education in advancing care.

Report

Multidisciplinary expert report

  • 15 minutes

Learn about the key challenges faced by members of the Alzheimer’s disease multidisciplinary care team when utilizing biomarkers and explore solutions proposed by the expert faculty.

Simulation

Shared decision-making patient simulation

  • 15 minutes

Engage in an immersive patient case simulation on shared decision-making, designed to enhance your ability to communicate about biomarker testing and its implications with patients.

Simulation

Escape the clinic

  • 15 minutes

Embark on an immersive, gamified learning experience where you’ll solve clues related to biomarkers in the diagnosis, management, and monitoring of early-stage Alzheimer’s disease. Can you escape the clinic?

Resource

Build your own infographic

  • 10 minutes

Build a personalized summary of best practices and clinical evidence on the use biomarkers to support diagnosis, treatment selection and monitoring in Alzheimer’s disease.

Resource

Navigating neuroimaging in Alzheimer’s care

An additional expert-led program designed to empower you with the latest insights, practical strategies, and real-world case studies on PET imaging in Alzheimer’s disease.

Learning objectives

Following completion of this independent educational program, you will be able to:

  • Evaluate the utility of current and emerging biomarkers to support an accurate diagnosis of early-stage Alzheimer's disease
  • Interpret the results of imaging and fluid biomarker tests for early-stage Alzheimer's disease
  • Apply biomarker testing to guide treatment selection for disease-modifying therapies and appropriate treatment monitoring
  • Establish a shared decision-making approach that prioritizes empathetic and clear communication with patients and caregivers throughout the biomarker testing process
Close
Headshot of Professor Dorota Religa smiling, with an out of focus indoor location in the background

Prof Dorota Religa

Professor / Senior Consultant

Karolinska Institutet, Sweden

Professor Dorota Religa – MD, PhD specializes in geriatrics, including neurogeriatrics, and is a full professor of geriatrics at Karolinska Institutet in Stockholm, Sweden. Professor Religa graduated from the Medical University of Warsaw in 1999 and obtained her PhD from Karolinska Institutet in 2006. Professor Religa is a Deputy Head of Division of Clinical Geriatrics at Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden, where she also works clinically. She conducts postgraduate/master’s studies in the field of Alzheimer’s disease for physicians. She is in the Board of the Swedish Geriatrics Society and the Medicines Committee of the Senior Health Initiative. Professor Religa is a member of the Academic Board at the European Geriatrics Society (EuGMS).

Disclosures

Nothing to disclose

Close
Headshot of Dr Carolyn Clevenger smiling, with an out of focus office wall in the background

Dr Carolyn Clevenger

Professor and Executive Director

Integrated Memory Care, Emory University, United States

Dr Carolyn Clevenger, gerontological nurse practitioner, is Professor at the Nell Hodgson Woodruff School of Nursing at Emory University. She is a Fellow of the American Association of Nurse Practitioners, and the Gerontological Society of America, and the American Academy of Nursing. Her research focuses the geriatric nurse practitioner workforce, psychoeducation programs for dementia family caregivers, and new models of care.

Disclosures

Consultant/Advisory Board: Braincheck, Eli Lilly, Novo Nordisk, Otsuka

All relevant financial relationships have been mitigated.

Close
Headshot of Professor Robert Perneczky smiling, with a simple white background

Prof Robert Perneczky

Professor of Translational Dementia Research

LMU Hospital, LMU Munich, Germany

Professor Robert Perneczky is a practicing psychiatrist and geriatrician and Professor of Translational Dementia Research and Director of the Division of Mental Health in Older Adults and Alzheimer Therapy and Research Center at Ludwig-Maximilians-University Munich and German Center for Neurodegenerative Diseases. He was previously Co-Director of the Neuroepidemiology Department at Imperial College London and until 2024 held a professorial chair at University of Sheffield. Professor Perneczky’s research focusses on dementia diagnoses, prevention and treatment. His studies apply a range of methodologies to advance the understanding of biological and clinical processes that lead to cognitive decline and associated disability. This includes imaging, fluid biomarkers, neuropsychological and lifestyle assessments in clinical and epidemiological contexts. Professor Perneczky has a Master of Business Administration degree from Warwick Business School and his more recent research interests include the readiness of healthcare systems for increased cognitive screening and uptake of future disease-modifying dementia treatments, and the collection of real-world evidence to support research and patient care. He is Founding Chairman of the International Registry for Alzheimer’s Disease and Other Dementias (InRAD) Foundation.

Disclosures

Employee/Owner: Medotrax
Grant/Research Support: GSK, Roche
Speakers Bureau/Honoraria for non-CME: Biogen, Eisai, Eli Lilly, Roche, Schwabe, Tabuk
Consultant/Advisory Board: Biogen, Bristol-Myers Squibb, Eisai, Eli Lilly, Roche

All relevant financial relationships have been mitigated.

Close
Headshot of Professor Hitoshi Shimada smiling, with an out of focus office in the background

Prof Hitoshi Shimada

Professor

Brain Research Institute, Niigata University, Japan

Professor Shimada obtained M.D. from Chiba University in 2003 and trained in Neurology at Chiba University Hospital and affiliated hospitals. He received Ph.D. degree in Advanced Life Science from Chiba University, Japan, in 2009. He was a postdoctoral researcher from April 2009, a researcher from December 2009, senior researcher from July 2014, and the principal researcher from July 2017 at the Department of Functional Brain Imaging Research, National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), Chiba, Japan. He has transferred to the Center for integrated human brain science (CIHBS) of Niigata University as a professor as of April 1st, 2021. He also became CIHBS center director in April 2024. His current research interests include molecular neuroimaging in neurodegenerative disorders, physiological background of psychiatric symptoms, mechanisms for maintaining homeostasis in the brain environment and its disruption

Disclosures

Grant/Research Support: Shimadzu, Splink
Speakers Bureau/Honoraria for non-CME: Biogen, Eisai, Eli Lilly, Kowa, Kyowa Kirin, Medi-Physicas, Nihon, PDR pharma, Shimadzu, Takeda

All relevant financial relationships have been mitigated.

Close
Headshot of Dr Chuck Vega smiling, with a simple blue background

Dr Chuck Vega

Clinical Professor of Family Medicine

UC Irvine, United States

Dr Chuck Vega grew up in Northern California and completed his undergraduate degree at Harvard University. He attended medical school at the University of Wisconsin – Madison and completed residency training in Family Medicine at UC Irvine. He stayed on as faculty in the Department of Family Medicine at UCI and now holds the title of Health Sciences Clinical Professor. He is the Director of UCI’s Program in Medical Education for the Latino Community and won a Macy Faculty Scholarship to improve patient-centered health education at UCI. He currently serves as Assistant Dean for Culture and Community Education in the UC Irvine School of Medicine.

Disclosures

Consultant/Advisory Board: Boehringer Ingelheim, Exact Sciences

All relevant financial relationships have been mitigated.

Close
Alzheimers Disease in the Biomarker Era

Home